Racial disparities in cancer therapy: Did the gap narrow between 1992 and 2002?

Cary P. Gross, Benjamin D. Smith, Elizabeth Wolf, Martin Andersen

Research output: Contribution to journalArticle

Abstract

BACKGROUND. The purpose of this study was to determine whether racial disparities in cancer therapy had diminished since the time they were initially documented in the early 1990s. METHODS. The authors identified a cohort of patients in the SEER-Medicare linked database who were ages 66 to 85 years and who had a primary diagnosis of colorectal, breast, lung, or prostate cancer during 1992 through 2002. The authors identified 7 stage-specific processes of cancer therapy by using Medicare claims. Candidate covariates in multivariate logistic regression included year, clinical, and sociodemographic characteristics, and physician access before cancer diagnosis. RESULTS. During the full study period, black patients were significantly less likely than white patients to receive therapy for cancers of the lung (surgical resection of early stage, 64.0% vs 78.5% for blacks and whites, respectively), breast (radiation after lumpectomy, 77.8% vs 85.8%), colon (adjuvant therapy for stage III, 52.1% vs 64.1%), and prostate (definitive therapy for early stage, 72.4% vs 77.2%, respectively). For both black and white patients, there was little or no improvement in the proportion of patients receiving therapy for most cancer therapies studied, and there was no decrease in the magnitude of any of these racial disparities between 1992 and 2002. Racial disparities persisted even after restricting the analysis to patients who had physician access before their diagnosis. CONCLUSIONS. There has been little improvement in either the overall proportion of Medicare beneficiaries receiving cancer therapies or the magnitude of racial disparity. Efforts in the last decade to mitigate cancer therapy disparities appear to have been unsuccessful.

Original languageEnglish (US)
Pages (from-to)900-908
Number of pages9
JournalCancer
Volume112
Issue number4
DOIs
StatePublished - Feb 15 2008
Externally publishedYes

Fingerprint

Neoplasms
Medicare
Therapeutics
Lung Neoplasms
Physicians
Segmental Mastectomy
Prostate
Prostatic Neoplasms
Colon
Breast
Logistic Models
Databases
Radiation
Breast Neoplasms
hydroquinone

Keywords

  • Access
  • Breast cancer
  • Colon cancer
  • Disparities
  • Lung cancer
  • Prostate cancer
  • Race

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Gross, C. P., Smith, B. D., Wolf, E., & Andersen, M. (2008). Racial disparities in cancer therapy: Did the gap narrow between 1992 and 2002? Cancer, 112(4), 900-908. https://doi.org/10.1002/cncr.23228

Racial disparities in cancer therapy : Did the gap narrow between 1992 and 2002? / Gross, Cary P.; Smith, Benjamin D.; Wolf, Elizabeth; Andersen, Martin.

In: Cancer, Vol. 112, No. 4, 15.02.2008, p. 900-908.

Research output: Contribution to journalArticle

Gross, CP, Smith, BD, Wolf, E & Andersen, M 2008, 'Racial disparities in cancer therapy: Did the gap narrow between 1992 and 2002?', Cancer, vol. 112, no. 4, pp. 900-908. https://doi.org/10.1002/cncr.23228
Gross, Cary P. ; Smith, Benjamin D. ; Wolf, Elizabeth ; Andersen, Martin. / Racial disparities in cancer therapy : Did the gap narrow between 1992 and 2002?. In: Cancer. 2008 ; Vol. 112, No. 4. pp. 900-908.
@article{6ae718b561e14f32b0ac83b3d1843708,
title = "Racial disparities in cancer therapy: Did the gap narrow between 1992 and 2002?",
abstract = "BACKGROUND. The purpose of this study was to determine whether racial disparities in cancer therapy had diminished since the time they were initially documented in the early 1990s. METHODS. The authors identified a cohort of patients in the SEER-Medicare linked database who were ages 66 to 85 years and who had a primary diagnosis of colorectal, breast, lung, or prostate cancer during 1992 through 2002. The authors identified 7 stage-specific processes of cancer therapy by using Medicare claims. Candidate covariates in multivariate logistic regression included year, clinical, and sociodemographic characteristics, and physician access before cancer diagnosis. RESULTS. During the full study period, black patients were significantly less likely than white patients to receive therapy for cancers of the lung (surgical resection of early stage, 64.0{\%} vs 78.5{\%} for blacks and whites, respectively), breast (radiation after lumpectomy, 77.8{\%} vs 85.8{\%}), colon (adjuvant therapy for stage III, 52.1{\%} vs 64.1{\%}), and prostate (definitive therapy for early stage, 72.4{\%} vs 77.2{\%}, respectively). For both black and white patients, there was little or no improvement in the proportion of patients receiving therapy for most cancer therapies studied, and there was no decrease in the magnitude of any of these racial disparities between 1992 and 2002. Racial disparities persisted even after restricting the analysis to patients who had physician access before their diagnosis. CONCLUSIONS. There has been little improvement in either the overall proportion of Medicare beneficiaries receiving cancer therapies or the magnitude of racial disparity. Efforts in the last decade to mitigate cancer therapy disparities appear to have been unsuccessful.",
keywords = "Access, Breast cancer, Colon cancer, Disparities, Lung cancer, Prostate cancer, Race",
author = "Gross, {Cary P.} and Smith, {Benjamin D.} and Elizabeth Wolf and Martin Andersen",
year = "2008",
month = "2",
day = "15",
doi = "10.1002/cncr.23228",
language = "English (US)",
volume = "112",
pages = "900--908",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Racial disparities in cancer therapy

T2 - Did the gap narrow between 1992 and 2002?

AU - Gross, Cary P.

AU - Smith, Benjamin D.

AU - Wolf, Elizabeth

AU - Andersen, Martin

PY - 2008/2/15

Y1 - 2008/2/15

N2 - BACKGROUND. The purpose of this study was to determine whether racial disparities in cancer therapy had diminished since the time they were initially documented in the early 1990s. METHODS. The authors identified a cohort of patients in the SEER-Medicare linked database who were ages 66 to 85 years and who had a primary diagnosis of colorectal, breast, lung, or prostate cancer during 1992 through 2002. The authors identified 7 stage-specific processes of cancer therapy by using Medicare claims. Candidate covariates in multivariate logistic regression included year, clinical, and sociodemographic characteristics, and physician access before cancer diagnosis. RESULTS. During the full study period, black patients were significantly less likely than white patients to receive therapy for cancers of the lung (surgical resection of early stage, 64.0% vs 78.5% for blacks and whites, respectively), breast (radiation after lumpectomy, 77.8% vs 85.8%), colon (adjuvant therapy for stage III, 52.1% vs 64.1%), and prostate (definitive therapy for early stage, 72.4% vs 77.2%, respectively). For both black and white patients, there was little or no improvement in the proportion of patients receiving therapy for most cancer therapies studied, and there was no decrease in the magnitude of any of these racial disparities between 1992 and 2002. Racial disparities persisted even after restricting the analysis to patients who had physician access before their diagnosis. CONCLUSIONS. There has been little improvement in either the overall proportion of Medicare beneficiaries receiving cancer therapies or the magnitude of racial disparity. Efforts in the last decade to mitigate cancer therapy disparities appear to have been unsuccessful.

AB - BACKGROUND. The purpose of this study was to determine whether racial disparities in cancer therapy had diminished since the time they were initially documented in the early 1990s. METHODS. The authors identified a cohort of patients in the SEER-Medicare linked database who were ages 66 to 85 years and who had a primary diagnosis of colorectal, breast, lung, or prostate cancer during 1992 through 2002. The authors identified 7 stage-specific processes of cancer therapy by using Medicare claims. Candidate covariates in multivariate logistic regression included year, clinical, and sociodemographic characteristics, and physician access before cancer diagnosis. RESULTS. During the full study period, black patients were significantly less likely than white patients to receive therapy for cancers of the lung (surgical resection of early stage, 64.0% vs 78.5% for blacks and whites, respectively), breast (radiation after lumpectomy, 77.8% vs 85.8%), colon (adjuvant therapy for stage III, 52.1% vs 64.1%), and prostate (definitive therapy for early stage, 72.4% vs 77.2%, respectively). For both black and white patients, there was little or no improvement in the proportion of patients receiving therapy for most cancer therapies studied, and there was no decrease in the magnitude of any of these racial disparities between 1992 and 2002. Racial disparities persisted even after restricting the analysis to patients who had physician access before their diagnosis. CONCLUSIONS. There has been little improvement in either the overall proportion of Medicare beneficiaries receiving cancer therapies or the magnitude of racial disparity. Efforts in the last decade to mitigate cancer therapy disparities appear to have been unsuccessful.

KW - Access

KW - Breast cancer

KW - Colon cancer

KW - Disparities

KW - Lung cancer

KW - Prostate cancer

KW - Race

UR - http://www.scopus.com/inward/record.url?scp=39049093871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39049093871&partnerID=8YFLogxK

U2 - 10.1002/cncr.23228

DO - 10.1002/cncr.23228

M3 - Article

C2 - 18181101

AN - SCOPUS:39049093871

VL - 112

SP - 900

EP - 908

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 4

ER -